美国 · 平台与数据 · Stocktwits
SMMT Stock Plunges Overnight On FDA Rejection — CAPR Holders Feel The Jitters Ahead Of Their Own FDA Test
详细摘要
SMMT shares plunged 20% overnight late Sunday after the FDA rejected its Ivonescimab-plus-chemotherapy application for a lung cancer indication.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (stocktwits.com)




